Norstella LinQ establishes a throughline between the company’s various subsidiaries, utilizing capabilities from Citeline, Evaluate, MMIT, Panalgo and The Dedham Group.

Norstella debuted its NorstellaLinQ data platform on Tuesday, an offering from the pharmaceutical intelligence solutions provider that aggregates and cleans real-world data from various sources to provide high quality, comprehensive patient information.

Utilizing Norstella’s proprietary forecasting, clinical, regulatory, payer, coverage and commercial intelligence data, NorstellaLinQ connects data across different brands and data sets, allowing users to gain a holistic view of patients.

Users can interact with the service by purchasing data to use in their preferred format or using pre-combined data for specific use cases.

Our AI capabilities are built to evolve—transforming data into insight, insight into action, and action into impact.